The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Epigenetic memory in induced pluripotent stem cells
Open accessAbstract
Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an ‘epigenetic memory’ of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer is more effective at establishing the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, conventional methods for the induction and maintenance of pluripotent state introduce a myriad of additional biological obstacles to effective application in stem-cell-derived therapeutics.”
From Induced pluripotency in the context of stem cell expansion bioprocess development, optimization, and manufacturing: a roadmap to the clinic (2021) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
A bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Self-citationGeneration of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Self-citationIrizarry, R. A., Ladd-Acosta, C., Wen, B., Wu, Z., Montano, C., Onyango, P., Cui, H., Gabo, K., Rongione, M., Webster, M., et al. (2009) · Nature Genetics · doi:10.1038/ng.298 · Cited by 2,177
Self-citationSoldner, F., Hockemeyer, D., Beard, C., Gao, Q., Bell, G. W., Cook, E. G., Hargus, G., Blak, A., Cooper, O., Mitalipova, M., et al. (2009) · Cell · doi:10.1016/j.cell.2009.02.013 · Cited by 1,549
Self-citationDissecting direct reprogramming through integrative genomic analysis
Mikkelsen, T. S., Hanna, J., Zhang, X., Ku, M., Wernig, M., Schorderet, P., Bernstein, B. E., Jaenisch, R., Lander, E. S., & Meissner, A. (2008) · Nature · doi:10.1038/nature07056 · Cited by 1,480
Self-citationAn Extended Transcriptional Network for Pluripotency of Embryonic Stem Cells
Kim, J., Chu, J., Shen, X., Wang, J., & Orkin, S. H. (2008) · Cell · doi:10.1016/j.cell.2008.02.039 · Cited by 1,332
Self-citationDynamic Reprogramming of DNA Methylation in the Early Mouse Embryo
Santos, F., Hendrich, B., Reik, W., & Dean, W. (2002) · Developmental Biology · doi:10.1006/dbio.2001.0501 · Cited by 1,212
Polo, J. M., Liu, S., Figueroa, M. E., Kulalert, W., Eminli, S., Tan, K. Y., Apostolou, E., Stadtfeld, M., Li, Y., Shioda, T., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1667 · Cited by 1,198
Cited by
Items 101–132 of 132
Molecular Obstacles to Clinical Translation of iPSCs
Tapia, N., & Schöler, H. R. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.06.017 · Cited by 141
Beagan, J. A., Gilgenast, T. G., Kim, J., Plona, Z., Norton, H. K., Hu, G., Hsu, S. C., Shields, E. J., Lyu, X., Apostolou, E., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.04.004 · Cited by 134
“Although there is some evidence of epigenetic traces from the somatic cell of origin (Bock et al., 2011; Kim et al., 2010; Polo et al., 2010), the emerging model is that ESC-like epigenetic and transcriptional states can be generally reset under proper reprogramming conditions (Stadtfeld et al.,…”
Self-citationThe Osteoblast to Osteocyte Transition: Epigenetic Changes and Response to the Vitamin D3Hormone
St. John, H. C., Bishop, K. A., Meyer, M. B., Benkusky, N. A., Leng, N., Kendziorski, C., Bonewald, L. F., & Pike, J. W. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1091 · Cited by 127
Pamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127
Reprogramming the epigenome with vitamin C
Lee Chong, T., Ahearn, E. L., & Cimmino, L. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00128 · Cited by 120
Herrero-Navarro, Á., Puche-Aroca, L., Moreno-Juan, V., Sempere-Ferràndez, A., Espinosa, A., Susín, R., Torres-Masjoan, L., Leyva-Díaz, E., Karow, M., Figueres-Oñate, M., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe8978 · Cited by 117
“The fact that epigenetic configurations are heritable through cell divisions (4, 38, 39) might confer astrocytes with a specific and long-lasting regional differentiation potential as may occur during injury-induced neurogenesis (40, 41).”
BackgroundiPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
Scesa, G., Adami, R., & Bottai, D. (2021) · Cells · doi:10.3390/cells10061470 · Cited by 110
Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes
Zhu, R., Blazeski, A., Poon, E., Costa, K. D., Tung, L., & Boheler, K. R. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt507 · Cited by 110
Wahlestedt, M., Norddahl, G. L., Sten, G., Ugale, A., Frisk, M.-A. M., Mattsson, R., Deierborg, T., Sigvardsson, M., & Bryder, D. (2013) · Blood · doi:10.1182/blood-2012-11-469080 · Cited by 106
Germain, P.-L., & Testa, G. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.05.012 · Cited by 94
Stem cell sources for vascular tissue engineering and regeneration
Bajpai, V. K., & Andreadis, S. T. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0264 · Cited by 95
Nuclear Wave1 Is Required for Reprogramming Transcription in Oocytes and for Normal Development
Miyamoto, K., Teperek, M., Yusa, K., Allen, G. E., Bradshaw, C. R., & Gurdon, J. B. (2013) · Science · doi:10.1126/science.1240376 · Cited by 91
Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89
“In addition, epigenetic signatures from source cells may reside in iPSCs due to incomplete reprogramming (Bar-Nur et al. 2011; Kim et al. 2010).”
Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNA
Jadhav, U., Cavazza, A., Banerjee, K. K., Xie, H., O’Neill, N. K., Saenz-Vash, V., Herbert, Z., Madha, S., Orkin, S. H., Zhai, H., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.024 · Cited by 86
Self-citationSharma, A., Jamil, M. A., Nuesgen, N., Schreiner, F., Priebe, L., Hoffmann, P., Herns, S., Nöthen, M. M., Fröhlich, H., Oldenburg, J., et al. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0112-2 · Cited by 81
Application of whole-organ tissue engineering in hepatology
Uygun, B. E., Yarmush, M. L., & Uygun, K. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.140 · Cited by 76
Linta, L., Stockmann, M., Kleinhans, K. N., Böckers, A., Storch, A., Zaehres, H., Lin, Q., Barbi, G., Böckers, T. M., Kleger, A., et al. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0026 · Cited by 65
Liu, T., Zhu, B., Liu, Y., Zhang, X., Yin, J., Li, X., Jiang, L., Hodges, A. P., Rosenthal, S. B., Zhou, L., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200474 · Cited by 64
Qiang, L., Fujita, R., & Abeliovich, A. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.002 · Cited by 59
Derakhshankhah, H., Sajadimajd, S., Jafari, S., Izadi, Z., Sarvari, S., Sharifi, M., Falahati, M., Moakedi, F., Muganda, W. C. A., Müller, M., et al. (2020) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2020.102149 · Cited by 48
Watanabe, S., Hirai, H., Asakura, Y., Tastad, C., Verma, M., Keller, C., Dutton, J. R., & Asakura, A. (2011) · Stem Cells · doi:10.1002/stem.598 · Cited by 44
Remyelination in the central nervous system
Franklin, R. J. M., Bodini, B., & Goldman, S. A. (2024) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a041371 · Cited by 40
Guo, L., Karoubi, G., Duchesneau, P., Shutova, M. V., Sung, H.-K., Tonge, P., Bear, C., Rogers, I., Nagy, A., & Waddell, T. K. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.022 · Cited by 33
Colter, J., Murari, K., Biernaskie, J., & Kallos, M. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00183-7 · Cited by 33
Pessôa, L. V. D. F., Pires, P. R. L., del Collado, M., Pieri, N. C. G., Recchia, K., Souza, A. F., Perecin, F., da Silveira, J. C., de Andrade, A. F. C., Ambrosio, C. E., et al. (2019) · Stem Cells International · doi:10.1155/2019/1393791 · Cited by 29
Jiang, Q., Huang, X., Hu, X., Shan, Z., Wu, Y., Wu, G., & Lei, L. (2020) · Stem Cells · doi:10.1002/stem.3188 · Cited by 27
FoxO3 regulates neuronal reprogramming of cells from postnatal and aging mice
Ahlenius, H., Chanda, S., Webb, A. E., Yousif, I., Karmazin, J., Prusiner, S. B., Brunet, A., Südhof, T. C., & Wernig, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607079113 · Cited by 26
Reprogramming cell fate: a changing story
Chin, M. T. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00046 · Cited by 18
Regulation of genomic output and (pluri)potency in regeneration
Duncan, E. M., & Sánchez Alvarado, A. (2019) · Annual Review of Genetics · doi:10.1146/annurev-genet-112618-043733 · Cited by 17
Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy
Li, Y., & Darabi, R. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30164 · Cited by 16
“This can be done using chromatin modifying agents or by their differentiation into a target lineage, followed by subsequent reprogramming into iPSCs, which significantly improves differentiation of newly generated iPSCs into target lineage.(56)”
BackgroundInfluentialTelomere dynamics in induced pluripotent stem cells: Potentials for human disease modeling
Ly, H. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i10.89 · Cited by 12
Gene and protein expression in human megakaryocytes derived from induced pluripotent stem cells
Kammers, K., Taub, M. A., Mathias, R. A., Yanek, L. R., Kanchan, K., Venkatraman, V., Sundararaman, N., Martin, J., Liu, S., Hoyle, D., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15334 · Cited by 10
Metadata
- Authors
- Kim, K., Doi, A., Wen, B., Ng, K., Zhao, R., Cahan, P., Kim, J., Aryee, M. J., Ji, H., Ehrlich, L. I. R., Yabuuchi, A., Takeuchi, A., Cunniff, K. C., Hongguang, H., Mckinney-Freeman, S., Naveiras, O., Yoon, T. J., Irizarry, R. A., Jung, N., Seita, J., Hanna, J., Murakami, P., Jaenisch, R., Weissleder, R., Orkin, S. H., Weissman, I. L., Feinberg, A. P., & Daley, G. Q.
- Venue
- Nature
- Published
- 2010-07-19
- Volume
- 467
- Issue
- 7313
- Pages
- 285-290
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2102560467
- Cited by
- 2,313
- References
- 54
- FWCI
- 98.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.